CryoCell International Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $5.53
- Today's High:
- $5.99
- Open Price:
- $5.9
- 52W Low:
- $2.69
- 52W High:
- $8.12
- Prev. Close:
- $5.85
- Volume:
- 3388
Company Statistics
- Market Cap.:
- $40.56 million
- Book Value:
- -0.081
- Revenue TTM:
- $30.90 million
- Operating Margin TTM:
- 14.96%
- Gross Profit TTM:
- $21.54 million
- Profit Margin:
- 8.76%
- Return on Assets TTM:
- 4.78%
- Return on Equity TTM:
- 151.87%
Company Profile
CryoCell International Inc had its IPO on 1997-01-21 under the ticker symbol CCEL.
The company operates in the Healthcare sector and Medical Care Facilities industry. CryoCell International Inc has a staff strength of 80 employees.
Stock update
Shares of CryoCell International Inc opened at $5.9 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $5.53 - $5.99, and closed at $5.53.
This is a -5.47% slip from the previous day's closing price.
A total volume of 3,388 shares were traded at the close of the day’s session.
In the last one week, shares of CryoCell International Inc have slipped by -6.11%.
CryoCell International Inc's Key Ratios
CryoCell International Inc has a market cap of $40.56 million, indicating a price to book ratio of 9.7236 and a price to sales ratio of 1.2029.
In the last 12-months CryoCell International Inc’s revenue was $30.90 million with a gross profit of $21.54 million and an EBITDA of $6.10 million. The EBITDA ratio measures CryoCell International Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, CryoCell International Inc’s operating margin was 14.96% while its return on assets stood at 4.78% with a return of equity of 151.87%.
In Q0.66666666666667, CryoCell International Inc’s quarterly earnings growth was a negative -7.8% while revenue growth was a positive 7.8%.
CryoCell International Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 15.7581
- PEG
- 0
Its diluted EPS in the last 12-months stands at $0.31 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CryoCell International Inc’s profitability.
CryoCell International Inc stock is trading at a EV to sales ratio of 1.4685 and a EV to EBITDA ratio of 9.5686. Its price to sales ratio in the trailing 12-months stood at 1.2029.
CryoCell International Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 2.73%.
Balance sheet and cash flow metrics
- Total Assets
- $66.13 million
- Total Liabilities
- $18.91 million
- Operating Cash Flow
- $-1201938.00
- Capital Expenditure
- $375600
- Dividend Payout Ratio
- 2.73%
CryoCell International Inc ended 2024 with $66.13 million in total assets and $0 in total liabilities. Its intangible assets were valued at $66.13 million while shareholder equity stood at $-687517.00.
CryoCell International Inc ended 2024 with $0 in deferred long-term liabilities, $18.91 million in other current liabilities, 148480.00 in common stock, $-20870701.00 in retained earnings and $1.94 million in goodwill. Its cash balance stood at $1.37 million and cash and short-term investments were $2.21 million. The company’s total short-term debt was $2,220,086 while long-term debt stood at $8.55 million.
CryoCell International Inc’s total current assets stands at $10.64 million while long-term investments were $308000.00 and short-term investments were $840277.00. Its net receivables were $6.52 million compared to accounts payable of $2.36 million and inventory worth $900052.00.
In 2024, CryoCell International Inc's operating cash flow was $-1201938.00 while its capital expenditure stood at $375600.
Comparatively, CryoCell International Inc paid $0.03 in dividends in 2024.
Other key metrics
- Current Trading Price
- $5.53
- 52-Week High
- $8.12
- 52-Week Low
- $2.69
- Analyst Target Price
- $10
CryoCell International Inc stock is currently trading at $5.53 per share. It touched a 52-week high of $8.12 and a 52-week low of $8.12. Analysts tracking the stock have a 12-month average target price of $10.
Its 50-day moving average was $6 and 200-day moving average was $4.77 The short ratio stood at 1.9 indicating a short percent outstanding of 0%.
Around 4758.6% of the company’s stock are held by insiders while 1258.6% are held by institutions.
Frequently Asked Questions About CryoCell International Inc
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.